Addressing the Challenge of Common Chronic Diseases — A View from the FDA
The New England Journal of Medicine
FEBRUARY 2, 2024
Collaboration between the FDA and other stakeholders could improve the way in which evidence is generated and interventions are developed and implemented to help address common chronic diseases.
Let's personalize your content